Stocks and Investing Stocks and Investing
Thu, May 7, 2020
Wed, May 6, 2020

Nathan Weinstein Maintained (ACST) at Strong Buy with Decreased Target to $103 on, May 6th, 2020


Published on 2024-10-27 05:31:52 - WOPRAI, Nathan Weinstein
  Print publication without navigation


Nathan Weinstein of Aegis Capital, Maintained "Acasti Pharma Inc." (ACST) at Strong Buy with Decreased Target from $144 to $103 on, May 6th, 2020.

Nathan has made no other calls on ACST in the last 4 months.



There is 1 other peer that has a rating on ACST. Out of the 1 peers that are also analyzing ACST, all agrees with Nathan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Mike Crawford of "B. Riley Securities" Downgraded from Strong Buy to Hold and Held Target at $96 on, Monday, January 13th, 2020
Contributing Sources